Geneos Wealth Management Inc. Collegium Pharmaceutical, Inc Transaction History

Geneos Wealth Management Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$14.22 - $20.88 $7,110 - $10,440	-500 Reduced 22.73%	1,700 $30,000
Q3 2021 Nov 09, 2021	BUY	$17.75 - $25.39 $39,050 - $55,858	2,200 New	2,200 $43,000
Q4 2020 May 19, 2021	SELL	$17.83 - $22.29 $80,234 - $100,305	-4,500 Closed	0 $0
Q2 2020 Sep 07, 2021	BUY	$15.49 - $23.51 $27,882 - $42,318	1,800 Added 66.67%	4,500 $73,000
Q1 2019 Sep 07, 2021	SELL	$13.58 - $18.72 $27,160 - $37,440	-2,000 Reduced 42.55%	2,700 $40,000
Q3 2018 Sep 07, 2021	BUY	$14.16 - $24.3 $66,552 - $114,210	4,700 New	4,700 $69,000

254

36.9M

100K

21.1K

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.12B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.